341 related articles for article (PubMed ID: 29843213)
41. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Chen L; Chu F; Cao Y; Shao J; Wang F
Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
[TBL] [Abstract][Full Text] [Related]
42. Dysregulation of serum miR-1204 and its potential as a biomarker for the diagnosis and prognosis of breast cancer.
Han S; Li P; Wang D; Yan H
Rev Assoc Med Bras (1992); 2020 Jun; 66(6):732-736. PubMed ID: 32696863
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
44. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
45. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S
Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897
[TBL] [Abstract][Full Text] [Related]
46. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
47. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
Sun B; Liu X; Gao Y; Li L; Dong Z
Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430
[TBL] [Abstract][Full Text] [Related]
48. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
Liu W; Zhao ZY; Shi L; Yuan WD
Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
[TBL] [Abstract][Full Text] [Related]
49. Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.
Liu B; Su F; Chen M; Li Y; Qi X; Xiao J; Li X; Liu X; Liang W; Zhang Y; Zhang J
Hum Pathol; 2017 Jun; 64():44-52. PubMed ID: 28412211
[TBL] [Abstract][Full Text] [Related]
50. Serum miR-3142 could be Used as a Potential Biomarker to Screen Cervical Cancer Patients from Healthy Controls.
Luo Q; Wang H; Li J
Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969093
[TBL] [Abstract][Full Text] [Related]
51. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F; Lu Z; Chen B; Dong P; Zheng J
Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
[TBL] [Abstract][Full Text] [Related]
52. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
53. Plasma miR-122 as a potential diagnostic and prognostic indicator in human glioma.
Tang Y; Zhao S; Wang J; Li D; Ren Q; Tang Y
Neurol Sci; 2017 Jun; 38(6):1087-1092. PubMed ID: 28367610
[TBL] [Abstract][Full Text] [Related]
54. A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.
Kleivi Sahlberg K; Bottai G; Naume B; Burwinkel B; Calin GA; Børresen-Dale AL; Santarpia L
Clin Cancer Res; 2015 Mar; 21(5):1207-14. PubMed ID: 25547678
[TBL] [Abstract][Full Text] [Related]
55. Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis.
Ahmadinejad F; Mowla SJ; Honardoost MA; Arjenaki MG; Moazeni-Bistgani M; Kheiri S; Teimori H
Tumour Biol; 2017 Aug; 39(8):1010428317698362. PubMed ID: 28857013
[TBL] [Abstract][Full Text] [Related]
56. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.
Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z
Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959
[TBL] [Abstract][Full Text] [Related]
57. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
[TBL] [Abstract][Full Text] [Related]
58. Expression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancer.
Li P; Dong J; Zhou X; Sun W; Huang H; Chen T; Ye B; Zheng Z; Lu M
Onco Targets Ther; 2017; 10():5711-5718. PubMed ID: 29238203
[TBL] [Abstract][Full Text] [Related]
59. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
Lin X; Wang Z; Wang Y; Feng W
Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
[TBL] [Abstract][Full Text] [Related]
60. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
Wu HK; Liu C; Fan XX; Wang H; Zhou L
Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]